Free Trial

Repligen (RGEN) Earnings Date, Estimates & Call Transcripts

Repligen logo
$124.89 -17.54 (-12.31%)
(As of 04:15 PM ET)

Repligen Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 19Estimated
Actual EPS
(Nov. 12)
$0.43 Beat By $0.09
Consensus EPS
(Nov. 12)
$0.34

Repligen announced Q3 2024 earnings on November 12, 2024, reporting an EPS of $0.43, which topped analysts' consensus estimates of $0.34 by $0.09. Quarterly revenue rose 9.7% year-over-year to $154.87 million, above the consensus estimate of $153.34 million. With a trailing EPS of -$0.37, Repligen's earnings are expected to grow 31.94% next year, from $1.44 to $1.90 per share.

RGEN Upcoming Earnings

Repligen's next earnings date is estimated for Wednesday, February 19, 2025, based off prior year's reporting schedules.

Get Repligen Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Repligen and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

RGEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RGEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Repligen Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$0.29$0.75$0.41 
Q2 20244$0.29$0.83$0.45 
Q3 20244$0.33$0.85$0.47 
Q4 20244$0.39$0.91$0.58 
FY 202416$1.30$3.34$1.90 
Q1 20253$0.39$0.48$0.44 
Q2 20253$0.47$0.53$0.49 
Q3 20253$0.42$0.52$0.47 
Q4 20253$0.52$0.62$0.58 
FY 202512$1.80$2.15$1.97 
Q1 20261$0.65$0.65$0.65 

Repligen Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/19/2025
(Estimated)
------- 
11/12/2024Q3 2024$0.34$0.43+$0.09$0.87$153.34M$154.87M    
7/30/2024Q2 2024$0.33$0.33-$0.60$154.11M$154.07M      
5/1/2024Q1 2024$0.29$0.28 -$0.01$0.52$150.06M$151.31M      
2/21/2024Q4 2023$0.33$0.33-$1.12$155.38M$155.74M      
10/31/2023Q3 2023$0.14$0.23+$0.09$0.14$140.68M$141.20M      
8/2/2023Q2 2023$0.49$0.53+$0.04$0.71$165.93M$159.20M      
“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!
5/2/2023Q1 2023$0.59$0.64+$0.05$0.77$181.43M$182.70M      
2/22/2023Q4 2022$0.58$0.68+$0.10$0.51$184.41M$186.80M      

Repligen Earnings - Frequently Asked Questions

Repligen has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates. Learn more on RGEN's earnings history.

Repligen issued an update on its FY 2024 earnings guidance on Tuesday, November, 12th. The company provided earnings per share guidance of 1.500-1.580 for the period, compared to the consensus EPS estimate of 1.430. The company issued revenue guidance of $630.0 million-$639.0 million.

In the previous quarter, Repligen (NASDAQ:RGEN) reported $0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $0.34 by $0.09. Learn more on analysts' earnings estimate vs. RGEN's actual earnings.

The conference call for Repligen's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Repligen's latest earnings report can be read online.
Read Transcript

Repligen (NASDAQ:RGEN) has a recorded annual revenue of $638.76 million.

Repligen (NASDAQ:RGEN) has a recorded net income of $41.58 million. RGEN has generated -$0.37 earnings per share over the last four quarters.

Repligen (NASDAQ:RGEN) has a forward price-to-earnings ratio of 87.42. The price/earnings-to-growth ratio is 4.36.

Repligen's earnings are expected to grow from $1.44 per share to $1.90 per share in the next year, which is a 31.94% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:RGEN) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners